Clinical Trial Update: The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating the influence of vascular burden, amyloid plaque, and tau protein in patients with vascular cognitive impairment and deme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Frontotemporal Dementia
• Vascular Cognitive Impairment

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal Dementia | Phase 2 | Status: UNKNOWN